You make a good point. Revenue flow is unpredictable in terms of dates, amounts and confidence. Hence, market doesn't know what to do.
Share volume is a trickle compared to DEC 2020. That was based on significant news and then a deal. Nothings since. To me that means when it happens it will be like snagging a bluefin tuna.
- Forums
- ASX - By Stock
- KZA
- Ann: GBM Agile opens to paxalisib in Europe
Ann: GBM Agile opens to paxalisib in Europe, page-12
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)